October 3, 2013
Nichi-Iko Pharmaceutical and South Korean biomedicine company Binex have inked a capital and business alliance, the Japanese drug maker said on October 2. Under the agreement, Nichi-Iko will tie-up with Binex for the business of biosimilars and obtain 12.6% of...read more